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KEY POINTS
 There is no standardized objective measure to make the diagnosis of attention-deficit/
hyperactivity disorder (ADHD); the diagnosis is made with a thorough clinical history.
 Patients suffering from ADHD have twice the lifetime risk of substance use disorders
compared with their non-ADHD peers.
 For athletes, the type of sport, level of play, and baseline health should be considered in
the decision to use medications for the treatment of ADHD.
 The use of stimulants, although beneficial in athletes, is not without risk and potential for
cardiovascular and thermoregulatory adverse events.
 In professional athletes who need treatment of ADHD, nonstimulants should be carefully
considered; when stimulants are used, long-acting stimulants are preferred.

INTRODUCTION

Attention-deficit/hyperactivity disorder (ADHD) is a chronic and pervasive heritable
neurobiological developmental disorder that can affect an individual throughout their
life span. For diagnosis, the core symptoms of ADHD are hyperactivity, impulsivity,
and/or inattention that emerge by age 12 years, cannot be due to another mental or
medical condition, and cause impairment in at least 2 settings. ADHD affects about
5% of the general population younger than 19 years and about 4% of adults.1 Because
of its prevalence and negative impact on multiple domains over the course of a person’s life, ADHD is considered a major health problem. The chapter provides an overview of ADHD from preschool to the adult years with a focus on its impact on athletes.
It will also provide context to the progressive and changing needs of the patient with
treatment recommendations for an athlete throughout every stage of their athletic
career.
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ATTENTION-DEFICIT/HYPERACTIVITY DISORDER ACROSS THE LIFE SPAN

ADHD occurs in approximately 2% to 5% of children in the preschool age group.2 The
impairments seen at this age are similar to those seen in older school age children.3
ADHD in these age groups is characterized by inattentive, hyperactive, and impulsive
behaviors. Struggling with social relationships and learning are common impairments
seen in these children; they commonly interrupt conversations, have poor coordination, and blurt out inappropriate comments. They are also more likely to be suspended, be in accidents, and sustain injuries.4 Preschoolers and older school age
children also demonstrate similar levels of psychiatric comorbidities, with the most
common being learning and language disabilities, oppositional defiant disorder,
conduct disorder, depression, and anxiety disorders.5 These behaviors can result in
poor peer relationships, which can lead to further isolation and low self-esteem
affecting the child academically and within the family unit. Research suggests that
the younger the age of onset of symptoms, the more likely the disorder will be severe
during childhood.6 Children who receive treatment have a better prognosis than those
who do not.7
Approximately 50% of children will continue to meet diagnostic criteria for ADHD
into adolescence. However, with development, hyperactivity, although still present,
lessens in severity. Developmentally, adolescence is a time when decisions about
life choices are made that could both positively and negatively affect an individual’s
future. In high school, adolescents must learn to function in an environment that is
often more demanding and less structured. The influence of peers becomes particularly important and issues around poor self-regulation can create difficulty. In addition,
several comorbid problems may arise that require treatment, such as antisocial personality characteristics, depression, anxiety, and substance abuse problems.8 In an
empirically based literature review, Gillberg and colleagues found that beginning in
their adolescent years, patients suffering from ADHD have twice the lifetime risk of
substance abuse compared with their non-ADHD peers.9 The adolescent years are
a time of transition when a young person learns of their personal responsibility for their
actions. By age 21 years, 95% of teenagers stop taking medication, and this decline is
unlikely due to resolution of symptoms,10 and this puts adolescent patients with ADHD
at greater risk for negative outcomes and could slow the successful transition from
adolescence to adulthood.
The estimated point prevalence of ADHD is about 4% in the adult general population.11 Thus, a substantial proportion of young adults continue to have symptoms or
associated problems that may require treatment. Indeed, current estimates suggest
that about half of the patients with childhood ADHD continue with symptoms into
adulthood.11 Similar to adolescence, impulsivity and hyperactivity tend to abate, but
attentional problems persist into adulthood.12 Adults often experience more difficulty
with procrastination, time management, and organization, which can be particularly
problematic for college students. Furthermore, most adults with ADHD can experience multiple negative life events related to academic underachievement, problematic
driving, underemployment or recurrent unemployment, imprisonment, and problems
with forming and maintaining relationships.13 Comorbid problems include mood and
anxiety disorders, emotional dysregulation, low frustration tolerance, irritability, anger,
insomnia, increased risk taking, and problems with alcohol and substance misuse.
Impulsivity may place patients at greater risk to injure themselves, resulting in higher
rates of traumatic brain injury and other injuries (Table 1).
ADHD symptoms often start in the preschool years, but children tend to be diagnosed only after entering school, when the difficulties of meeting the academic
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demands become apparent and the child exhibits behavioral or cognitive deficits. The
male-female prevalence ratio of the disorder is 3:1 in children with equal male-tofemale ratios in adults.11 Because there is no standardized objective measure to
make the diagnosis of ADHD, the diagnosis is made after a thorough clinical history.
Review of standardized validated symptomatology questionnaires can help the diagnostic evaluation.
Patient evaluation regardless of the age should include gathering collateral information from parents, teachers, and in adults, partners or coworkers. When making the
diagnosis, it is also important to screen for psychiatric and cardiac and other medical
comorbidities to ensure that medications, if indicated, can be safely prescribed. The
clinician should assess and compare the person’s behavior with developmental norms
in multiple settings including home, work, and school to ensure that function and
impairment warrant intervention. Following the clinical diagnosis, the individual can
be assigned a treatment that is tailored to their needs.
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER ACROSS THE LIFE SPAN OF AN
ATHLETE
Preschool and Elementary Years

ADHD is a common psychiatric disorder in both the general population and in athletes.
Young athletes are a unique patient population. The preschool and elementary years
Table 1
Attention-deficit/hyperactivity disorder concerns over a life span
Age of
Patient

Developmental Impact

Preschool

 Behavioral disturbance

School-age







Behavioral disturbance
Poor social interactions
Academic difficulty
Poor peer acceptance
Comorbid conditions

Adolescent








Low self-esteem
Poor social interactions
Impulsivity
Academic difficulty
Smoking/substance use
Comorbid conditions

College-age







Low self-esteem
Academic difficulty
Substance abuse
Injury/accidents
Relationship problems

Adult

 Low self-esteem
 Not coping with tasks such
as bill paying
 Unemployment or
underemployment
 Relationship problems
 Driving issues
 Substance abuse
 Mood instability
 Imprisonment
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are the most likely time for the diagnosis of ADHD. Young athletes may experience
more problems with balance and coordinated activity.14 These children often present
with behavior issues, which contribute to strain on the parent, child, and family; this
strain may result in the subsequent development of depression, self-blame, and social
isolation in the parent.
Hyperactivity is more common in children than in adults. In one quasi-experimental
study comparing 34 male children (6–17 years) with ADHD with 41 children without
ADHD, Johnson and Rosen found that male athletes with ADHD displayed higher
levels of aggression, emotional reactivity, and frequency of disqualification.15 In one
retrospective review, children with ADHD were also more likely to be injured than children without ADHD in noncompetitive play.16 Nevertheless, sports can be a good
outlet for children with excess energy, and many kids find that playing sports is a place
where they can excel. In addition, research has shown that exercise may decrease
inattention and impulsive behaviors.17 Organized sports can be helpful in providing
structure, expectations, and rules. Participation in sports has also been shown to
decrease symptoms of anxiety and depression.18 The impact of a positive coaching
experience is one way to build on the confidence of those struggling with ADHD
who may have low self-esteem.
Middle School and High School Years

As athletes develop and enter adolescence, the unique challenges of this age group
could emerge especially for those with ADHD. For middle school and high school athletes, with parental consent, the coaching staff should be informed about the diagnosis of ADHD and whether the athlete is taking medication. This important
information allows the staff to monitor the athlete during practice and competition
for potential negative side effects. The designated sport and position need to be
considered in the overall treatment decisions for an athlete with ADHD. At this level
of play, participation is more important than competition. Being part of a team,
learning new skills, and enjoying physical activity typically outweigh the value of winning. This, in combination with academic requirements and success, needs to be
considered when creating a comprehensive treatment plan.
College Athletes

Although symptoms of ADHD may be present before college, some students do not
receive a diagnosis of ADHD until they are challenged by the academic expectations
of the college environment. Greater independence, more temptations for unhealthy
behaviors, a lack of parental regulation, lack of structure, and the need for more personal time management could lead to the surfacing of issues related to undiagnosed
ADHD, all compounding the athlete’s ability to succeed. Because by this age many
people experience an abatement of the hyperactivity symptoms, the predominant presentation includes low attention, focus, and concentration. Previous school records,
reports from people who know the athlete, and current stressors can all aid in making
the diagnosis.
Professional Athletes

The prevalence of ADHD in elite athletes is challenging to determine because the
stigma against mental health assessment and treatment is strong within this population.19 Unfortunately, poor focus, low frustration tolerance, low self-esteem, argumentativeness, and mood lability found in ADHD could impair the performance of an elite
athlete, making the diagnosis and treatment of this disorder critical to their success. A
review by Regnart and colleagues showed that mood disorders and substance use
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS
North America) from ClinicalKey.com by Elsevier on October 11, 2021. For personal use only.
No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

ADHD and Sports

disorders are also common in adult athletes with ADHD.20 Screening for these conditions is an important part of the elite athlete’s health management strategy.
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT OPTIONS

The ADHD literature describes a wide variety of psychological treatments, with or
without the use of stimulant and nonstimulant medication options. Psychological
treatment interventions include supportive psychotherapy, cognitive behavior therapy, support groups, parent training, educator/teacher training, biofeedback, medications, and social skills training. The National Institute of Mental Health Multimodal
Treatment of ADHD study showed that the use of stimulants was more efficacious
than psychosocial management alone, combined treatment, and routine care in the
community.21 Approximately 75% of those with ADHD note some benefit with psychostimulants,22 and thus, if diagnosed correctly, treatment of ADHD with a stimulant
is a favored approach.
Stimulants act on the neurotransmitters that block the reuptake of dopamine and
norepinephrine that are responsible for increasing attention and concentration. Stimulants also have a rapid onset, typically within 1 hour, with various durations of action
depending on the formulation, giving patients an almost immediate effect. There is
also some role for nonstimulant medications such as atomoxetine, bupropion, and
guanfacine for patients in whom stimulants may not be an option (Table 2). The major
benefit to nonstimulants is the absence of both psychological and physiologic abuse
concerns. However, in clinical practice, many patients report that nonstimulant options are not as effective at reducing their symptoms as stimulants.
The age of the patient can affect the treatment recommendation. According to a review by Young and Amarasinghe, the most appropriate treatment of preschoolers is
parent training.23 For school-aged children with moderate impairment, group parent
training and classroom behavioral interventions are typically recommended. For
more severe impairment, these interventions are more appropriate when combined
with stimulant medication. In considering the development of a comprehensive treatment plan, behavioral treatment can be particularly effective. Behavioral treatments
for younger children should include consequences that are concrete, frequent, and
coincide directly with the concerning behavior, and this allows the child to connect
their negative behavior with the consequence. For older children, cognitive skills
training can be taught to address social and achievement-related issues and will
give the child some autonomy and ownership in their treatment.
Interventions that include the integration of home and school strategies, psychopharmacology, and some component of social skills training are best suited for middle
school and adolescent children. For adolescence, treatment decisions cannot simply
be imposed by an authority figure. Accepting medication needs to be negotiated and
agreed on by the adolescent whose collaboration and agreement is critical to ensure
treatment compliance.
Stimulant medication is generally first-line treatment of adults, but cognitive behavioral therapy coaching, group therapy, and marital therapy have also been found to be
helpful. Regardless of the developmental stage, for patients to experience the highest
level of remission and symptom abatement, treatments must also address the individual’s daily adaptive functioning and their comorbid problems.
As individuals move into late adolescence and adulthood, treatments involving a
cognitive behavioral perspective are likely to become increasingly helpful.23 Recommendations regarding academic support and accommodations should be considered
a necessary part of the treatment plan. Regardless of the age of the individual,
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Table 2
Common attention-deficit/hyperactivity disorder medications and common side effects
Category

Generic Name

Trade Name

Stimulants

Methylphenidate

Decreased appetite,
Concerta, Ritalin,
weight loss, sleep
Metadata, Focalin,
difficulties,
Methylin, Quillivant,
nervousness, irritability,
Daytrana
hypertension,
tachycardia
Adderall, Adderall XR, Decreased appetite,
Mydayis
weight loss, sleep
difficulties,
nervousness, irritability,
hypertension,
tachycardia
Dexedrine, Dextrostat Decreased appetite,
weight loss, sleep
difficulties,
nervousness, irritability,
hypertension,
tachycardia
Vyvanse
Decreased appetite,
weight loss, sleep
difficulties,
nervousness, irritability,
hypertension,
tachycardia

Mixed
dextroamphetamineamphetamine salts

Dextroamphetamine

Lisdextroamphetamine

Nonstimulants Atomoxetine HCL

Strattera

Bupropion

Wellbutrin, Zyban

Guanfacine

Intuniv, Tenex

Common Side Effects

Fatigue, sedation, dry
mouth, GI upset,
increased sweating,
hypertension. Rarely
increased suicidality
and hepatotoxic
Anorexia, tics,
nervousness, potential
seizures
Sleepiness, drowsiness,
dizziness, headache,
irritability, low blood
pressure, nausea,
stomach pain, dry
mouth, constipation,
and decreased appetite

Abbreviation: GI, gastrointestinal.

clinicians should ensure that the goals and method of treatment are tangible and motivating. Thus, treatments should be modified at key developmental transitions using
developmentally sensitive strategies that place the patient’s most debilitating behaviors in the context of their level of understanding and ability to participate in their
treatment.
COMMON MEDICATION SIDE EFFECTS

The benefit of stimulants must be weighed against the potential risks. Common side
effects include decreased appetite, headache, gastrointestinal upset, and insomnia.
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Cardiovascular side effects include rapid heart rate and increased blood pressure.
There has been concern of sudden cardiac death from the use of stimulants for
ADHD. However, review of the literature by Perrin and colleagues did not support
this, and in 2008, a policy statement in the American Academy of Pediatrics recommended electrocardiogram screening only if there are concerning history or physical
examination findings or a strong family history of predisposing cardiac conditions.24
Prescribing clinicians should take a careful personal and family cardiac history and
monitor the athlete’s blood pressure and heart rate both before initiating treatment
and during follow-up appointments (Box 1).
Another potential side effect of stimulants is the increased risk of heat illness, which
is a common cause of death in athletes.25 It is associated with physical activity and
defined as the body’s inability to regulate and offset the increase in core body temperature. The risk of developing heat illness increases for athletes on stimulants because
of their effects on the body’s regulatory system, interfering with normal thermoregulation by altering neurotransmitter activity in the brain. When prescribing stimulants to
athletes, clinicians should monitor the athlete’s weight and vital signs, alert them of
the risk of heat illness, and educate them on the signs of heat-related illness, especially for those who participate in activities requiring sustained cardiovascular exertion
such as cycling or cross-country running.
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND CONCUSSION

There is an overlap in the clinical presentations of ADHD and concussion. In a crosssectional study of 8056 high school and collegiate athletes, Nelson found that individuals with ADHD had a greater rate of baseline fatigue, poor concentration, insomnia,
difficulty remembering, and balance problems, all of which can mimic the symptoms
of a concussion.26 This study also found that ADHD and learning disabilities place an
athlete at 2 to 3 times the risk for repetitive concussive injuries. In addition, individuals
with ADHD have been reported to have a continued decline on repeat neurocognitive
testing scores after concussion.27 A study by Biederman comparing 29 student athletes with ADHD with a historical sample of subjects without ADHD suggested that

Box 1
Cardiovascular screening
Personal History Questions
1. What is your history of heart murmurs, hypertension, chest pain, and palpitations?
2. Do you have a history of structural cardiac defects?
3. Have you ever had a cardiac event?
4. When was your last EKG? What were the results?
5. Have you ever had a history of any cardiac disease?
6. Have you ever had a history of any respiratory disease?
Family History Questions
1. Is there any family history of cardiac disease?
2. Has anyone in your family ever died young of a cardiac disease?
Cardiovascular Examination
1. Measure heart rate
2. Measure blood pressure
3. Cardiac auscultation looking for murmur
4. EKG if any of the aforementioned history is positive
Abbreviation: EKG, electrocardiogram.
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this may be due to worsening inattention from ADHD rather than from concussion
although this is a complex analysis, as concussion itself can cause inattention.28
Furthermore, ADHD has been reported to slow the recovery of a concussion for up
to 3 days.29 Although recovery can be lengthened, some research shows that there
does not seem to be a risk of developing chronic or worsened ADHD symptoms after
concussion, whereas other research showed that children with ADHD had more significant symptoms of inattention after a closed head injury than controls.25
All of these points make the evaluation and management of concussion more complex in this patient population. The prolonged recovery time and confusing clinical picture can make it difficult to determine when it is safe to recommend the athlete return
to academics and to play. Therefore, clinicians should proceed with caution and
consider a multidisciplinary approach. If at the time of injury, symptoms are well
controlled, despite limited evidence, accepted practice is to continue medications.30
SPECIAL TREATMENT CONSIDERATIONS FOR ATHLETES

When prescribing treatment of athletes, there are unique challenges that must be
considered. The clinician caring for these athletes must customize care and treatment
recommendations to accommodate an athlete’s needs. Because the presentation,
diagnosis, and treatment of athletes can change across the life span, the age of the
athlete, their health status, student status, and the severity of their symptoms must
be taken into consideration by the treating clinician. Except in very young athletes,
stimulant medication with or without a psychological intervention is generally firstline treatment of ADHD. Because of high levels of intense exercise and activity, the
physiologic and potential psychological effects of stimulants on athletes is a valid
concern. When considering a stimulant medication, risk of diversion and potential
for abuse should also be considered. For these reasons, long-acting agents should
be considered as first-line stimulant treatment.
In children and adolescents, coaching that is structured and organized will result in
the greatest benefit. Complicated instructions may need to be broken down into
smaller pieces. Rules may need to be repeated. The home environment can play a major role, and homes that provide structure, calmness, and consistency can help a child
or adolescent with ADHD perform their best.
Athletics and academics present an interesting dynamic; athletes with ADHD may
be more attracted to physical activity than to academics because of inherent restlessness, internal reward-seeking benefits, and natural drive for competitiveness.
Conversely, the struggle in the academic setting can lead to low confidence and
poor self-esteem. It cannot be overstated that effective treatment not only improves
quality of life and academic performance but also has demonstrated a decrease in
the rate of substance abuse, driving errors, and the prevalence of comorbid psychological disorders. Balancing the dilemma between patient needs and the potential for
serious side effects and unfair advantage in play due to stimulant use should be
considered when deciding whether to recommend a stimulant or other nonstimulant
strategies and psychological interventions.
In terms of the treatment of ADHD in college-aged or professional athletes, many
sports leagues and organizations follow the guidelines established by the World
Anti-Doping Agency, which allows therapeutic use exemption (TUE) to permit athletes
to take stimulants if deemed necessary by their physicians.31 TUE is a newer policy, as
stimulants were previously listed on the World Anti-Doping Agency–banned list due to
their ergogenic potential. For athletes participating in college sports under the supervision of the National College Athletic Association (NCCA), stimulants require TUE in
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order for athletes to take stimulants without sanction.32 There has been much controversy and confusion about the rules and regulations around the use of stimulants by
these governing bodies. Although the nonstimulant option, atomoxetine, is US Food
and Drug Administration approved for the treatment of ADHD, neither governing
body requires a trial of atomoxetine before a stimulant trial.33
Rates of use of stimulants by NCAA college athletes is not inconsequential. A drug
use survey done in 2012 by the NCAA indicated that 4.3% of student athletes reported
using stimulants with a prescription, whereas 6.3% of student athletes reported using
stimulants without a physician’s prescription, leaving the possibility that medication
may be given to or sold to the athlete by friends and peers.34 Abuse of stimulants
for recreation and performance improvement is a valid concern.
Treatment decisions in the elite athlete are complicated by concerns related to fair
competition. At this level of competition even the tiniest advantage can make a significant difference between winning or losing. When prescribing stimulants in professional sports, clinicians must follow the specific guidelines for therapeutic use
exemptions outlined by professional organizations such as Major League Baseball
and the National Football League.35,36 However, a bigger question is whether
performance-enhancing agents should even be allowed at the elite level of sports.
With the goal of fair play central to any sport, Reardon and Factor argue that all
performance-enhancing agents including stimulants should either be completely prohibited or only prohibited during practice and play, thereby removing some of the
ethical and medical concerns associated with their use.33 Garner and colleagues
argue that the banning of stimulants does not necessarily guarantee fair play and
may contribute to poor social functioning and low self-esteem.37 When making this
decision, one should consider the evidence for increased risk of injury during play in
inattentive athletes who are not being treated with effective medications.
The severity of symptoms and degree of impairment need to be considered when
deciding whether to prescribe stimulants in a professional athlete. If medication is clinically necessary for an elite athlete, nonstimulant medication, such as atomoxetine,
should be explored. For athletes with comorbid depression, there is some clinical evidence that bupropion, an antidepressant with some stimulant properties, may be
helpful as an off-label for the treatment of ADHD.
Regardless of the age of the ADHD athlete, the designated sport and position need
to be considered in the overall treatment decisions. Working with the athlete on the
timing of the medication, such that it is most effective during academic sessions,
should be explored. As a clinician, when providing treatment, the main goal is to
develop a strategy that helps the athlete achieve success both academically and as
an athlete, while remaining compliant with published sports governing body regulations. This customized strategy makes sense when the athlete is also a student and
must obtain continued academic success in order to advance. However, when the
athlete is an adult playing a professional sport, the use of stimulants should be used
only after careful consideration. In making this decision, clinicians should consider issues related to the likelihood of performance enhancement, accuracy of the ADHD
diagnosis, policies of sports governing bodies and potential for diversion and abuse.
SUMMARY

ADHD is a common neurodevelopmental psychiatric disorder that affects both athletes and nonathletes. Those with ADHD who participate in sports find that it can be
mutually beneficial, as these individuals can naturally excel as well as have an outlet
for symptom management. The diagnosis and treatment of ADHD is critical to the
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optimal functioning and quality of life of those who struggle with this condition. The
focus of treatment should be on psychological interventions with or without medications. The use of stimulants should be carefully reviewed and factor in the age, level
of play and sport, and the health of the athlete. If stimulants are used, long-acting stimulants are preferred as first-line stimulant treatment.
Psychological interventions such as cognitive behavioral therapy, individual education plans; behavior modification therapy; caregiver support; parent teaching/training;
and ADHD education for the patient, family, and coaches should be explored and recommended. In addition to these interventions, a comprehensive treatment plan should
also include recommendations for healthy nutrition and physical exercise, as data
have supported the benefit of both of these strategies. When impairment is moderate
or severe, psychostimulant medication still remains first-line treatment of the abatement of ADHD symptoms. Treatment should not be avoided in student athletes. In
professional athletes, treatment with stimulants should only be used after carefully
weighing the risks and benefits, and nonstimulants should be carefully considered. Ultimately, pharmacotherapy with or without psychosocial interventions play a fundamental role in the management of ADHD athletes across their life span.
CLINICS CARE POINTS
 Younger children and athletes with ADHD, often present with comorbid behavioral
problems.
 Unmitigated ADHD impacts performance in sports and academic/ vocational tasks.
 Age-appropriate psychosocial interventions should be considered along with medication
management.
 Healthy nutrition, sleep hygiene and physical exercise related education should be included
in a treatment plan for ADHD.
 Stimulant medications are highly effective and should be considered in athletes after
judicious review of clinical presentation.
 Practitioners treating collegiate, amateur and professional athletes should make themselves
aware of specific regulations of the specific sport governing bodies.
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